Clene (CLNN)

• Market cap: $65.4M
• 1 day: 1.99%
• 5 days: -5.19%
• 1 month: -14.81%
• 3 months: -36.71%
• 6 months: 19.91%
• Year to date: -11.27%
• 1 year: 36.9%
• 5 years: -96.91%
• 10 years: -97.35%
• Sector: Consumer Staples
• Industry: Packaged Foods

About: Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Employees: 79